J1439 HCPCS code: Injection, ferric carboxymaltose, 1 mg
J1439 is the HCPCS Level II code for injection, ferric carboxymaltose, 1 mg. In 2024 Medicare paid an average of $0.87 per service for J1439 across 48,977,066 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 1000 per day on outpatient hospital claims. Medicare volume fell 18% from 2022 to 2024 (60,093,517 to 48,977,066 services). In 2024, about 4,190 clinicians billed Medicare for J1439 for 29,775 beneficiaries; New York, California, Florida accounted for 28% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2015-01-01 |
| Last action effective | 2015-01-01 |
Who bills J1439 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 4,190 |
| Medicare beneficiaries | 29,775 |
| States with claims | 49 |
| Share of services in top 3 states (New York, California, Florida) | 28% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1439, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 60,093,517 | 36,126 | $1.11 | $0.88 |
| 2023 | 58,870,857 | 35,298 | $1.10 | $0.87 |
| 2024 | 48,977,066 | 29,775 | $1.09 | $0.87 |
States with the most J1439 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| New York | 5,248,176 | $0.87 |
| California | 4,738,229 | $0.87 |
| Florida | 3,701,505 | $0.87 |
| New Jersey | 3,428,468 | $0.87 |
| Illinois | 3,060,891 | $0.87 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 1000 | Prescribing Information |
| practitioner claims | 1000 | Prescribing Information |
What changed for J1439
- 2015-01-01: J1439 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1439?
J1439 is the HCPCS Level II code for injection, ferric carboxymaltose, 1 mg. Short descriptor: "Inj ferric carboxymaltos 1mg".
How much does Medicare pay for J1439?
In 2024, the average Medicare payment was $0.87 per service (average allowed $1.09).
Does Medicare cover J1439?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J1439 can be billed per day?
1000 on outpatient hospital claims; 1000 on practitioner claims (NCCI medically unlikely edits).
Related J14 codes
- J1410 — Injection, estrogen conjugated, per 25 mg
- J1411 — Injection, etranacogene dezaparvovec-drlb, per therapeutic dose
- J1412 — Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes
- J1413 — Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose
- J1414 — Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose
- J1426 — Injection, casimersen, 10 mg
- J1427 — Injection, viltolarsen, 10 mg
- J1428 — Injection, eteplirsen, 10 mg
- J1429 — Injection, golodirsen, 10 mg
- J1430 — Injection, ethanolamine oleate, 100 mg
- J1434 — Injection, fosaprepitant (focinvez), 1 mg
- J1435 — Injection, estrone, per 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1439
- Watch J1439 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1439
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.